<DOC>
	<DOCNO>NCT00859287</DOCNO>
	<brief_summary>This open label , non-interventional study compare efficacy Omepral® tablet treatment except proton pump inhibitor ( PPIs ) treatment various type acid reflux relate symptom patient reflux esophagitis .</brief_summary>
	<brief_title>Omepral® Tablets Special Clinical Experience Investigation Patients With Erosive Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<criteria>Patients newly diagnose erosive esophagitis history erosive esophagitis confirm endoscopy . Patients answer questionnaire quality life ( QOLRADJ ) , symptom severity frequency treatment satisfaction . During past 1 week , patient either two day heartburn acid taste mouth severity Patients receive treatment proton pump inhibitor , make stomach acid decrease last 4 week prior enrolment . Patients answer questionnaire quality life ( QOLRADJ ) , symptom severity frequency treatment satisfaction . Patients include previously study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Reflux esophagitis</keyword>
	<keyword>Omepral®</keyword>
	<keyword>QOLRAD</keyword>
</DOC>